App-Quantinova.ai

EVALUATION OF SERUM LEVELS OF N-TERMINAL PROB-TYPE NATRIURETIC PEPTIDE (NT-PROBNP) IN PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS (PM/DM): PRELIMINARY DATA

S. Barsotti - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Heart muscle disease

Carvedilol

MYOCARDIAL PERFUSION AND EQUILIBRIUM RADIOISOTOPE VENTRICULOGRAPHY IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AS A SCRUTINY METHOD FOR THE DETECTION OF ASYMPTOMATIC CARDIOMYOPATHY

S. Munoz Lopez - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Methadone hydrochloride

CARDIAC INVOLVEMENT IN ANKYLOSING SPONDYLITIS IN A TUNISIEN POPULATION

S. Boussaid - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Heart muscle disease

N/A

ANCA-ASSOCIATED VASCULITIS IN A COMMUNITY-BASED TEACHING HOSPITAL IN JAPAN

H. Oshikawa - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

Cyclophosphamide

ERK5 IS A NOVEL REGULATOR OF PLATELET ACTIVATION AND CONTRIBUTES TO INFARCT EXPANSION AND CARDIAC DYSFUNCTION AFTER MYOCARDIAL INFARCTION

Scott Cameron - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Heart muscle disease

Hydrogen peroxide

RELEASE KINETICS OF GALECTIN-3, GDF-15 AND NT-PROBNP IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Christoph Liebetrau - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

RIGHT BUNDLE BRANCH BLOCK IN CARDIOMYOPATHY IS ASSOCIATED WITH INCREASED VENTRICULAR TACHYCARDIA/FIBRILLATION AND CARDIAC MORTALITY

Omair Yousuf - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CROSS CORRELATION OF TISSUE DOPPLER MYOCARDIAL ACCELERATION AT BASELINE BEFORE CARDIAC RESYNCHRONIZATION THERAPY IS A MARKER FOR SUBSEQUENT VENTRICULAR ARRHYTHMIAS

Bhupendar Tayal - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

LEFT VENTRICULAR NON-COMPACTION ASSESSED BY CARDIAC MAGNETIC RESONANCE IMAGING IS ASSOCIATED WITH INCREASED VENTRICULAR ARRHYTHMIAS

Daniel Zakhary - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CORRELATION BETWEEN POSITRON EMISSION TOMOGRAPHY STRESS MYOCARDIAL BLOOD FLOW AND VENTRICULAR TACHYARRHYTHMIA OR DEATH IN PATIENTS WITH CARDIOMYOPATHY

Saima Karim - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CATHETER ABLATION OF VENTRICULAR TACHYCARDIA: TEN-YEAR TRENDS IN UTILIZATION, IN-HOSPITAL COMPLICATIONS, AND IN-HOSPITAL MORTALITY IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY

Prakash Harikrishnan - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

EXPERIENCE WITH WEARABLE CARDIOVERTER-DEFIBRILLATOR IN NON-ISCHEMIC CARDIOMYOPATHY: A NATIONAL DATABASE ANALYSIS

Negar Salehi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

CARDIAC DIAGNOSES IN SURVIVORS OF CARDIAC ARREST WITH CULPRIT-FREE CORONARY ANGIOGRAMS

Howell J. Williams - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

N/A

HIGH RATE OF VENTRICULAR ARRHYTHMIAS IN WOMEN WITH PERIPARTUM CARDIOMYOPATHY AND IMPLANTED CARDIOVERTER DEFIBRILLATORS

Maria Elena DeBenedetti Zunino - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

APPROPRIATE AND INAPPROPRIATE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: INCIDENCE AND PREDICTORS

David B. Min - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

INCIDENCE AND PREDICTORS OF SUDDEN CARDIAC DEATH FOLLOWING HEART TRANSPLANTATION

Kairav Vakil - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

SUCCESSFUL IMPLANT OF THE SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN PATIENTS WITH LOW BODY MASS INDEX

Faiz Ali Subzposh - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

WHAT NUMBER OF MORPHOLOGICAL TYPES OF VENTRICULAR PREMATURE BEATS PREDICTS POOR PROGNOSIS IN SUBJECTS WITH NON-ISCHEMIC CARDIOMYOPATHY?

Koya Ozawa - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CLINICAL OUTCOMES OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION VERSUS SINUS RHYTHM

Paul Chacko - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

HYPONATREMIA AND HEMODYNAMIC CHANGES FOLLOWING PERCUTANEOUS LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT DEVICE

Ryan Maybrook - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Filters

3340 Abstracts